Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas

Human Pathology

Volumn 28, Issue 3, 1997, Pages 270-276

  Sheyn, I ^a   Noffsinger, A E ^a   Heffelfinger, S ^a   Davis, B ^a   Miller, M A ^a   Fenoglio Preiser, C M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

amplification; cyclin; FISH; immunohistochemistry; squamous cell carcinoma

Indexed keywords

CYCLIN D1;

ANUS CARCINOMA; ARTICLE; CARCINOGENESIS; CHROMOSOME 11; ESOPHAGUS CARCINOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; PROTO ONCOGENE; SQUAMOUS CELL CARCINOMA;

EID: 0031049383     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90123-4     Document Type: Article

References (42)

1. Ali IU, Merlo G, Callahan R, et al: The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci. Oncogene 4:89-92, 1989
2. Jares P, Fernandez PL, Campo E, et al: PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54:4813-4817, 1994
3. Callender T, Elnaggar AK, Lee MS, et al: PRAD-1 (CCND1) cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74:152-158, 1994
4. Gillett C, Fantl V, Smith R, et al: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54:1812-1817, 1994
5. Zhou DJ, Casey G, Cline MJ: Amplification of human int-2 gene in breast cancers and squamous carcinomas. Oncogene 2:279-282, 1988
6. Berenson JR, Koga H, Yang J, et al: Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. Oncogene 5:1343-1348, 1990
7. Somers K, Cartwright S, Schechter G: Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene 5:915-920, 1990
8. Leonard JH, Kearsley JH, Chenevix-Trench G, et al: Analysis of gene amplification in head and neck squamous cell carcinomas. Int J Cancer 48:511-515, 1991
9. Berenson JR, Yang J, Mickel R: Frequent amplification of the bd-l locus in head and neck squamous cell carcinomas. Oncogene 4:1111-1116, 1989
10. Lidereau R, Callahan R, Dickson C, et al: Amplification of the int-2 gene in primary human breast tumors. Oncogene Res 2:285-291, 1988
11. Varley JM, Walker RA, Casey G, et al: A common alteration to the int-2 protooncogene in DNA from primary breast carcinomas. Oncogene 3:87-91, 1988
12. Theillet C, Adnane J, Szepetowski P, et al: BCL-1 participates in the 11q13 amplification found in breast cancer. Oncogene 5:147-149, 1990
13. Tsuda H, Hirohashi S, Shimosato Y, et al: Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ ear-1. Cancer Res 49:3104-3108, 1989
14. Fantl V, Richards MA, Smith R, et al: Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. Eur J Cancer 26:423-429, 1990
15. Borg A, Sigurdsson H, Clark GM, et al: Association of INT2/ HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br J Cancer 63:136-142, 1991
16. Saint-Ruf C, Malfoy B, Scholl S, et al: Gstπ gene is frequently co-amplified with INT2 and HSTF1 proto-oncogenes in human breast cancers. Oncogene 6:403-406, 1991
17. Schuuring E, Verhoeven E, Mooi WJ, et al: Identification and cloning of two overexpressed genes U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7:355-361, 1992
18. Speicher MR, Howe C, Crotty P, et al: Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 55:1010-1013, 1995
19. Wagata T, Ishizaki K, Imamura M, et al: Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas, Cancer Res 51:2113-2117, 1991
20. Adelaide J, Monges G, Derderian C, et al: Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br J Cancer 71:64-68, 1994
21. Jaing W, Zhang Y-J, Kahn SM, et al: Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci U S A 90:9026-9030, 1993
22. Mori M, Tokino T, Yanagisawa A, et al: Association between chromosome 11q13 amplification and prognosis of patients with oesophageal carcinomas. Eur J Cancer 28A:755-757, 1992
23. Kitagawa Y, Ueda M, Ando N, et al: Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res 51:1504-1508, 1991
24. Gramlich TL, Fritsch CR, Maurer D, et al: Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma. Diagn Mol Pathol 3:255-259, 1994
25. Zukerberg LB, Yang W-I, Gadd M, et al: Cyclin D1 (PRAD1) protein expression in breast cancer: Approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol 8:560-567, 1995
26. Buckley MF, Sweeney KJE, Hamilton JA, et al: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127-2133, 1993
27. Motokura T, Bloom T, Kim HG, et al: A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350:512-515, 1991
28. Arnold A, Kim HG, Gaz RD, et al: Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 83:2034-2040, 1989
29. Tsujimoto Y, Yunis J, Onorato-Showe L, et al: Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 224:1403-1406, 1985
30. Freshney RI: Culture of Animal Cells: A Manual of Basic Technique. New York, NY, Wiley-Liss, 1987, pp 169-185
31. Dickson C, Peters G: Potential oncogene product related to growth factors. Nature 326:823, 1987 (letter)
32. Casey G, Smith R, McGillivray D, et al: Characterization and chromosome assignment of human homolog of int-2, a potential proto-oncogene. Mol Cell Biol 6:502-510, 1986
33. Yoshida T, Miyagawa K, Odagiri H, et al: Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factor and the int-2 encoded protein. Proc Natl Acad Sci U S A 84:7305-7309, 1987
34. Peters G, Brookes S, Smith R, et al: The mouse homolog of the hst/K-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors. Proc Natl Acad Sci U S A 86:5678-5682, 1989
35. Scherr CJ: Mammalian G1 cyclins. Cell 73:1059-1065, 1993
36. Theillet C, Roy XL, Lapeyriere OD, et al: Amplification of FGF-related genes in human tumors: Possible involvement of HST in breast carcinomas. Oncogene 4:915-922, 1989
37. Liscia DS, Merlo GR, Garrett C, et al: Expression of int-2 mRNA in human tumors amplified at the int-2 locus. Oncogene 4:1219-1224, 1989
38. Lammie GA, Fand V, Smith R, et al: D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439-444, 1991
39. Bartkova J, Luka J, Muller H, et al: Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57:353-361, 1994
40. Jiang W, Kahn SM, Tomita N, et al: Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52:2980-2983, 1992
41. Michalides R, van Veelen N, Hart A, et al: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 35:975-978, 1995
42. Kuzrock R, Ku S, Talpaz M: Abnormalities in the PRAD1 (cyclin D1/bcl-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. Cancer 75:584-590, 1995